Since its first application in 1957 between identical twins,
1 the indications for allogeneic hematopoietic stem cell transplant have evolved substantially. Although the availability of a human leukocyte antigen–matched bone marrow graft from a sibling was considered essential in the early days of transplantation, advances in the techniques required to use alternative donors or perform transplantation in older recipients have expanded transplant access in the modern age to a far broader spectrum of patients. In the 1960s, the procedure was considered by some to be ethically questionable. In 2019, allogeneic hematopoietic stem cell transplant volumes in Europe and North America reached almost 30 000 cases.
2 Identify all potential conflicts of interest that might be relevant to your comment. Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. Err on the side of full disclosure. If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response. Not all submitted comments are published. Please see our commenting policy for details.